A detailed history of Hunting Hill Global Capital, LLC transactions in Catalent, Inc. stock. As of the latest transaction made, Hunting Hill Global Capital, LLC holds 9,011 shares of CTLT stock, worth $543,633. This represents 0.36% of its overall portfolio holdings.

Number of Shares
9,011
Previous 14,516 37.92%
Holding current value
$543,633
Previous $819,000 38.22%
% of portfolio
0.36%
Previous 0.48%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 17, 2024

SELL
$53.58 - $57.02 $294,957 - $313,895
-5,505 Reduced 37.92%
9,011 $506,000
Q1 2024

May 15, 2024

BUY
$42.56 - $59.82 $617,800 - $868,347
14,516 New
14,516 $819,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.9B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Hunting Hill Global Capital, LLC Portfolio

Follow Hunting Hill Global Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hunting Hill Global Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hunting Hill Global Capital, LLC with notifications on news.